Nurses Take A Lesson In mHealth
The MacMillan m-learning courses, which can be used on Apple, Android and BlackBerry devices, cover subjects such as teamwork, time management, appraisals, managing change, coaching, interviewing and managing stress and assertiveness. The app created by Video Arts, provides a gateway to the courses available through Learn Zone, MacMillan’s virtual learning environment. Learn Zone contains education and support resources, advice and guidance, e-learning courses and professional development tools.
Lesley Maguire, Macmillan's Learning Technology Manager, said, “Smartphones and tablet computers are everywhere now and most people are comfortable in using them for a variety of applications.
“M-learning takes advantage of this technology and enables people to learn whenever and wherever they want. The mobile courses will benefit our staff and they'll add value to the quality of the service that our professionals provide to cancer sufferers.”
Designed specifically for mobile devices and for on-the-move learning, the courses can be used as standalone learning resources or to reinforce the messages from classroom training or e-learning.
The Move To m-Learning In The Healthcare Industry
This development signals to the fact that mHealth and m-learning is gaining momentum within the medical and healthcare industry. mHealth goes way beyond electronic health records and mobile diagnosis, it also facilitates greater communication and on-the-spot learning.
The medical industry, due to its very nature is innovative and thus ever changing, so it’s paramount that information and training is accessible instantly, remotely and at any time of day. MacMillan’s move to m-learning is just the very beginning.
Read More About mHealth In Healthcare Global
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”